NCT04242017View on ClinicalTrials.gov

Long-term Better Than Short-term ADT With Salvage RT

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

394

Participants

Timeline

Start Date

July 7, 2020

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2031

Conditions
Prostate Cancer
Interventions
DRUG

Triptoreline

Comparison of the duration of ADT (Triptoreline)

Trial Locations (3)

Unknown

RECRUITING

AZ Maria Middelares, Ghent

RECRUITING

UZ Gent, Ghent

RECRUITING

UZ Leuven, Leuven

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

Universitaire Ziekenhuizen KU Leuven

OTHER